These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12653766)

  • 1. Schnitzler's syndrome: successful treatment of two patients using thalidomide.
    Worm M; Kolde G
    Br J Dermatol; 2003 Mar; 148(3):601-2. PubMed ID: 12653766
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.
    de Koning HD; Bodar EJ; Simon A; van der Hilst JC; Netea MG; van der Meer JW
    Ann Rheum Dis; 2006 Apr; 65(4):542-4. PubMed ID: 16096327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.
    de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A
    Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
    Benítez Gutiérrez L; Mellor Pita S; Tutor de Ureta P; Yebra Bango M
    Med Clin (Barc); 2013 May; 140(9):427-8. PubMed ID: 23177777
    [No Abstract]   [Full Text] [Related]  

  • 5. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin.
    Pascual-López M; Hernández-Núñez A; Sánchez-Pérez J; Fernández-Herrera J; García-Díez A
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):267-70. PubMed ID: 12195569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schnitzler's syndrome: diagnosis, treatment, and follow-up.
    Simon A; Asli B; Braun-Falco M; De Koning H; Fermand JP; Grattan C; Krause K; Lachmann H; Lenormand C; Martinez-Taboada V; Maurer M; Peters M; Rizzi R; Rongioletti F; Ruzicka T; Schnitzler L; Schubert B; Sibilia J; Lipsker D
    Allergy; 2013; 68(5):562-8. PubMed ID: 23480774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of Schnitzler's syndrome with interferon alfa-2b.
    Kuenzli S; Buchet S; Saurat JH
    Dermatology; 2002; 205(1):74. PubMed ID: 12145442
    [No Abstract]   [Full Text] [Related]  

  • 8. A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra.
    Ahn MJ; Yu JE; Jeong J; Sim DW; Koh YI
    Yonsei Med J; 2018 Jan; 59(1):154-157. PubMed ID: 29214791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anakinra and Schnitzler's syndrome].
    Saiz E; Gálvez J; Mora A; Contreras L
    Med Clin (Barc); 2008 Mar; 130(9):358-9. PubMed ID: 18373918
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Schnitzler's syndrome with anakinra.
    Gilson M; Abad S; Larroche C; Dhote R
    Clin Exp Rheumatol; 2007; 25(6):931. PubMed ID: 18173934
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial response to cyclosporine in a patient with Schnitzler's syndrome.
    Carbone J; Paravisini A; Sarmiento E; Rodríguez-Molina J; Fernández-Cruz E
    Allergol Immunopathol (Madr); 2007; 35(2):71-3. PubMed ID: 17428403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic treatment of a case of Schnitzler's syndrome with pamidronate.
    Wendling D; Prati C; Hoen B; Toussirot E; Streit G; Dumoulin G
    Joint Bone Spine; 2008 Jul; 75(4):507-8. PubMed ID: 18486515
    [No Abstract]   [Full Text] [Related]  

  • 13. Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment.
    Kastritis E; Katoulis A; Terpos E; Panayiotides I; Gavriatopoulopu M; Dimopopoulos MA
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):359-62. PubMed ID: 19064402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of anti-IL1 in Schnitzler's syndrome.
    Klemmer N; Lenain P; Balguerie X; Le Loët X
    Joint Bone Spine; 2007 Oct; 74(5):509-10. PubMed ID: 17921021
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful use of anakinra to treat refractory Schnitzler's syndrome.
    Dybowski F; Sepp N; Bergerhausen HJ; Braun J
    Clin Exp Rheumatol; 2008; 26(2):354-7. PubMed ID: 18565263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed development of the IgM paraprotein in Schnitzler's syndrome.
    Mulla E; Neame R
    Scand J Rheumatol; 2015; 44(6):521-2. PubMed ID: 26395927
    [No Abstract]   [Full Text] [Related]  

  • 18. Schnitzler's syndrome: what's new?
    Almerigogna F; Giudizi MG; Cappelli F; Romagnani S
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):214-9. PubMed ID: 12195558
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiological aid to clinical diagnosis of Schnitzler's syndrome: multimodality imaging approach.
    Flórez AF; Gallardo Agromayor E; García-Barredo R; Landeras Alvaro RM; Gorriño Angulo M; Martínez-Taboada VM; Fernández Echevarría MA
    Clin Rheumatol; 2008 Jan; 27(1):107-10. PubMed ID: 17982708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.
    Gran JT; Midtvedt Ø; Haug S; Aukrust P
    Scand J Rheumatol; 2011 Jan; 40(1):74-9. PubMed ID: 20936987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.